Page 1 of 2
`
`Important Safety Information | Full Product Information
`1-844-4MY-TEARS
`(1-844-469-8327)
`
`HOME
`
`CHRONIC DRY EYE DISEASE
`
`LEARN ABOUT RESTASIS®
`
`TAKE ACTION
`
`SAVINGS & SUPPORT
`
`FAQs
`
`Savings & Support
`
`Get Savings & Support
`
`Program Benefits
`
`FAQs
`
`The My Tears, My Rewards®
`Program Gives You Instant
`Savings on Every Prescription Plus
`Ongoing Support With Treatment
`
`Eligible Patients Get Instant Savings on Both 90-Day
`and 30-Day Prescriptions
`
`Approved Use
`RESTASIS® and RESTASIS
`MultiDose™ Ophthalmic Emulsion
`help increase your eyes’ natural
`ability to produce tears, which may
`be reduced by inflammation due to
`Chronic Dry Eye. RESTASIS® and
`RESTASIS MultiDose™ did not
`increase tear production in patients
`using anti-inflammatory eye drops
`or tear duct plugs.
`Important Safety Information
`Do not use RESTASIS® and
`RESTASIS MultiDose™ Ophthalmic
`Emulsion if you are allergic to any
`of the ingredients. Be careful not to
`touch the container tip to your eye
`or other surfaces, to help avoid eye
`injury and contamination.
`See more below >
`
`Additional Program Benefits
`• Customized counseling communications to help you on your treatment
`journey
`• Special offers to help you save on RESTASIS® and REFRESH®
`Lubricant Eye Drops
`• Toll-free customer support line 1-844-4MY-TEARS (1-844-469-8327)
`where trained representatives and nurses can answer your questions
`about treatment and the program—support available in 190 languages
`• Dosing reminders when you use the free MyTears® iPhone app to track
`your progress
`
`https://www.restasis.com/Savings-and-Support/Program-Benefits
`
`MYLAN - EXHIBIT 1116
`Mylan Pharmaceuticals Inc. et al. v. Allergan, Inc.
`IPR2016-01127, -01128, -01129, -01130, -01131, & -01132
`
`

`

`Page 2 of 2
`
`*Members whose prescriptions will be paid for in part or in whole by Medicare, Medicaid, or any
`similar federal or state healthcare program, are not eligible for savings or rebates according to
`federal and state law.
`
`The actual savings on your out-of-pocket costs for RESTASIS® will vary according to refill quantity,
`personal healthcare insurance coverage, and adherence to FDA dosing guidelines. Please review
`the My Tears, My Rewards® Program guidelines to learn more.
`
`Approved Use
`RESTASIS® and RESTASIS MultiDose™ Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by
`inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose™ did not increase tear production in patients using anti-inflammatory eye
`drops or tear duct plugs.
`
`Important Safety Information
`Do not use RESTASIS® and RESTASIS MultiDose™ Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container
`tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose™ should not be used while wearing
`contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose™ and may be reinserted after 15
`minutes.
`
`The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body
`sensation, itching, stinging, and blurred vision.
`
`You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
`
`Click here for full Product Information for RESTASIS® and RESTASIS MultiDose™.
`
`Dr. Tendler is an actual RESTASIS® patient and is compensated for appearing on this website.
`
`© 2017 Allergan, Inc. All rights reserved | Privacy Statement | Terms of Use | Contact Us | RES103038_v6 04/17
`This information is intended for residents of the United States. All trademarks are the property of their respective owners.
`
`https://www.restasis.com/Savings-and-Support/Program-Benefits
`
`